Clinical significance of cation channel antibodies in motor neuron disease

Muscle and Nerve

Volumn 54, Issue 2, 2016, Pages 228-231

  Donaldson, Rachel ^a   Li, Jianbo ^a   Li, Yuebing ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

amyotrophic lateral sclerosis; autoimmunity; ganglionic acetylcholine receptor antibody; motor neuron disease; voltage gated calcium channel antibody; voltage gated potassium channel complex antibody

Indexed keywords

ANTIBODY; ANTINUCLEAR ANTIBODY; GANGLIONIC ACETYLCHOLINE RECEPTOR ANTIBODY; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL ANTIBODY; VOLTAGE GATED POTASSIUM CHANNEL ANTIBODY;

ADULT; ALS FUNCTIONAL RATING SCALE REVISED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CANCER SCREENING; CASE CONTROL STUDY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; INCIDENCE; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; NEOPLASM; NEUROLOGIC DISEASE ASSESSMENT; PRIORITY JOURNAL;

EID: 84978906383     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.25046     Document Type: Article

References (22)

1. See comment in PubMed Commons below Lennon VA, Kryzer TJ, Griesmann GE, O'Suilleabhain PE, Windebank AJ, Woppmann A, et al. Calcium-channel antibodies in the Lambert–Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 1995;332:1467–1474.
2. Nwosu VK, Royer JA, Stickler DE. Voltage gated potassium channel antibodies in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2010;11:392–394.
3. McKeon A, Lennon VA, Lachance DH, Fealey RD, Pittock SJ. Ganglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompaniments. Arch Neurol 2009;66:735–741.
4. McKeon A, Pittock SJ, Lennon VA. CSF complements serum for evaluating paraneoplastic antibodies and NMO-IgG. Neurology 2011;76:1108–1110.
5. Brooks BR, Miller RG, Swash M, Munsat TL; World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293–299.
6. Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 1999;169:13–21.
7. See comment in PubMed Commons below Kimura F, Fujimura C, Ishida S, Nakajima H, Furutama D, Uehara H, et al. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology 2006;66:265–267.
8. Smith RG, Kimura F, Harati Y, McKinley K, Stefani E, Appel SH. Altered muscle calcium channel binding kinetics in autoimmune motoneuron disease. Muscle Nerve 1995;18:620–627.
9. Stich C, Kleer B, Rauer S. Absence of paraneoplastic antineuronal antibodies in sera of 145 patients with motor neuron disease. J Neurol Neurosurg Psychiatry 2007;78:883–885.
10. Vernino S, Lennon VA. Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability. Muscle Nerve 2002;26:702–707.
11. Appel SH, Smith RG, Engelhardt JI, Stefani E. Evidence for autoimmunity in amyotrophic lateral sclerosis. J Neurol Sci 1993;118:169–174.
12. Montojo MT, Petit-Pedrol M, Graus F, Dalmau J. Clinical spectrum and diagnostic value of antibodies against the potassium channel related protein complex. Neurologia 2015;30:295–301.
13. Bekircan-Kurt CE, Derle Çiftçi E, Kurne AT, Anlar B. Voltage gated calcium channel antibody-related neurological diseases. World J Clin Cases 2015;3:293–300.
14. Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies N Engl J Med 2000;343:847–855.
15. Huda S, Wong SH, Pettingill P, O'Connell D, Vincent A, Steiger M. An 11-year retrospective experience of antibodies against the voltage-gated potassium channel (VGKC) complex from a tertiary neurological centre. J Neurol 2015;262:418–424.
16. Vincent A, Buckley C, Schott JM, Baker I, Dewar BK, Detert N, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004;127:701–712.
17. Drachman DB, Chaudhry V, Cornblath D, Kuncl RW, Pestronk A, Clawson L, et al. Trial of immunosuppression in amyotrophic lateral sclerosis using total lymphoid irradiation. Ann Neurol 1994;35:142–150.
18. Tan E, Lynn DJ, Amato AA, Kissel JT, Rammohan KW, Sahenk Z, et al. Immunosuppressive treatment of motor neuron syndromes. Attempts to distinguish a treatable disorder. Arch Neurol 1994;51:194–200.
19. Verma A, Berger JR, Snodgrass S, Petito C. Motor neuron disease: a paraneoplastic process associated with anti-hu antibody and small-cell lung carcinoma. Ann Neurol 1996;40:112–116.
20. See comment in PubMed Commons below Lee JI, Macht S, Albrecht P, Hartung HP, Goebels N. Brachial amyotrophic diparesis associated with anti-Hu positive anterior horn cell disease and autonomic disorder. J Neurol 2013;260:301–302.
21. Sato A, Sakai N, Shinbo J, Hashidate H, Igarashi S, Kakita A, et al. An autopsy case of amyotrophic lateral sclerosis with prominent muscle cramps, fasciculation, and high titer of anti-voltage gated potassium channel (VGKC) complex antibody. Rinsho Shinkeigaku 2014;54:32–37.
22. Corcia P, Gordon PH, Camdessanche JP. Is there a paraneoplastic ALS? Amyotroph Lateral Scler Frontotemporal Degener 2015;16:252–257.